ArticleAlzheimer's research & therapy2024

Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.

Matthew D Howe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.